SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017181
Filing Date
2022-08-15
Accepted
2022-08-15 06:04:22
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20220630.htm   iXBRL 10-Q 3150843
2 EX-31.1 elym-ex31_1.htm EX-31.1 19818
3 EX-31.2 elym-ex31_2.htm EX-31.2 19876
4 EX-32.1 elym-ex32_1.htm EX-32.1 12788
5 EX-32.2 elym-ex32_2.htm EX-32.2 12867
6 GRAPHIC img156756083_0.jpg GRAPHIC 33690
  Complete submission text file 0000950170-22-017181.txt   10197753

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20220630.xsd EX-101.SCH 52319
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20220630_lab.xml EX-101.LAB 415861
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20220630_pre.xml EX-101.PRE 315845
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20220630_cal.xml EX-101.CAL 36884
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20220630_def.xml EX-101.DEF 154797
62 EXTRACTED XBRL INSTANCE DOCUMENT elym-20220630_htm.xml XML 2080124
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 221162085
SIC: 2834 Pharmaceutical Preparations